Neurology News

A growing amount of evidence, albeit limited in its strength, suggests that auditory and vestibular effects should be added to the list of symptoms linked to COVID-19, according to an expert.

The FDA granted fast track designation to DA01, a stem cell-based therapy, for the treatment of advanced Parkinson’s disease.

Among older adults, all measures of ambulatory BP were associated with risk for stroke while office diastolic BP was only weakly associated, and central BP measures were not associated with stroke at all, researchers reported.

Racial and ethnic minority groups were “markedly underrepresented” in outpatient practices across most medical specialties, and those disparities persisted even after researchers accounted for social determinants of access to care.

A CDC advisory committee said that it strongly supports the continued use of the Johnson & Johnson COVID-19 vaccine, despite its potential link to Guillain-Barré syndrome.

Several factors, including pediatric ICU admission and multispecialty care, increased length of stay and costs at pediatric neurology hospitals, according to results of a retrospective review published in Journal of Child Neurology.

Mindfulness-Based Therapy for Insomnia effectively improved subjective and objective sleep quality among older adults, according to results from a randomized clinical trial published in Psychological Medicine.

In a phase 3 trial of pimavanserin that came to a premature halt for efficacy, patients with dementia-related psychosis who continued the treatment had a lower risk for relapse than those who were switched to placebo, researchers reported.

Toxoplasma gondii seropositivity appeared linked to mild cognitive impairment in multiple cognitive domains, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

Patients who had a stroke had steeper declines in cognitive and daily functioning up to 10 years prior to their first stroke compared with those who never had a stroke.